Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
600671
Rank in Stocks
#14571
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, a company founded in... Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd, a company founded in 1958 and based in Hangzhou, China, operates a multifaceted business primarily focused on the pharmaceutical sector. Through its various subsidiaries, the company specializes in both the production and distribution of medicines throughout China. Its extensive product range includes the manufacturing and sale of a diverse array of pharmaceuticals and health-related goods. These encompass various dosage forms such as tablets, granules, pills, mixtures, oral liquids, syrups, eye drops, and soft capsules, as well as a selection of health foods. Beyond finished products, Hangzhou TianMuShan is also involved in the trade of raw materials like menthol and peppermint oil. The company also offers a comprehensive selection of traditional Chinese medicine, including prepared formulas, individual herbal pieces, and fresh herbs. Furthermore, it provides specialized medical services such as custom decoction preparation and delivery, herbal slicing and powder grinding, and traditional Chinese medicine diagnosis and treatment. In addition to its core pharmaceutical activities, the enterprise has diversified into other ventures, including software development, remote health management solutions, commercial property administration, food services, and internet information businesses.
Share Price
$2.59
Last synced: 2026-11-10
Market Cap
$315.36M
Change (1 day)
-0.23%
Change (1 year)
-2.86%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671)
Category
Healthcare
Operating Margin for Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671)
Operating Margin as of November 2026 TTM: 5.05%
According to Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's latest financial reports, its current operating margin (TTM) is 5.05%. At the end of 2025 the company had an operating margin of 6.60%.
Operating Margin history for Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 5.05% | -23.48% |
| 2025 | 6.60% | -42.91% |
| 2024 | 11.56% | -137.47% |
| 2023 | -30.85% | -51.92% |
| 2022 | -64.17% | 148.34% |
| 2021 | -25.84% | -5.83% |
| 2020 | -27.44% | -281.48% |
| 2019 | 15.12% | -1,487.16% |
| 2018 | -1.09% | -84.04% |
| 2017 | -6.83% | 143.93% |
| 2016 | -2.80% | -87.52% |
| 2015 | -22.44% | -1,012.20% |
| 2014 | 2.46% | 186.05% |
| 2013 | 0.86% | -102.52% |
| 2012 | -34.09% | -413.62% |
| 2011 | 10.87% | -304.71% |
| 2010 | -5.31% | -76.03% |
| 2009 | -22.15% | 6,612.12% |
| 2008 | -0.33% | -103.42% |
| 2007 | 9.64% | 2,310.00% |
| 2006 | 0.40% | -86.75% |
| 2005 | 3.02% | -33.77% |
| 2004 | 4.56% | -192.49% |
| 2003 | -4.93% | -246.73% |
| 2002 | 3.36% | -38.91% |
| 2001 | 5.50% | -12.97% |
| 2000 | 6.32% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 46.07% | -90.88% |
US
|
|
| 25.70% | -94.91% |
US
|
|
| 35.53% | -92.96% |
US
|
|
| 16.24% | -96.78% |
US
|
|
| 31.92% | -93.68% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin is 5.05%, as of Nov 2026.
What was Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin in 2025?
In 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin was 6.60%, compared with 11.56% in 2024.
How has Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin changed since 2020?
From 2020 to 2025, Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin was highest in 2024 (11.56%) and lowest in 2022 (-64.17%).
How does Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin compare with similar companies?
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd's operating margin (5.05%) is lower than that of all 5 similar companies listed above. The highest among them is Eli Lilly and Company, with 46.07%.